Evidence map›Paper›PMID 41167691›Full record

ArticleIn vivo (Athens, Greece)

Diagnosis of Chemotherapy-induced Peripheral Neurotoxicity: A Scoping Review.

Valentina Cerrone, Dalila Esposito, Mario Montedoro, Vincenzo Andretta, Matteo Luigi Giuseppe Leoni, Arturo Cuomo, Sabrina Bimonte, Marco Cascella

Abstract readScoping Review
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Valentina CerroneAnesthesia and Pain Medicine, Department of Medicine, Surgery and Dentistry Scuola Medica Salernitana, University of Salerno, Baronissi, Italy.
Dalila EspositoAnesthesia and Pain Medicine, Department of Medicine, Surgery and Dentistry Scuola Medica Salernitana, University of Salerno, Baronissi, Italy.
Mario MontedoroAnesthesia and Pain Medicine, Department of Medicine, Surgery and Dentistry Scuola Medica Salernitana, University of Salerno, Baronissi, Italy.
Vincenzo AndrettaAnesthesia and Pain Medicine, Department of Medicine, Surgery and Dentistry Scuola Medica Salernitana, University of Salerno, Baronissi, Italy.
Matteo Luigi Giuseppe LeoniDepartment of Medical and Surgical Sciences and Translational Medicine, Sapienza University of Rome, Rome, Italy.
Arturo CuomoDepartment of Anesthesia and Critical Care, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy.
Sabrina BimonteDepartment of Anesthesia and Critical Care, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Naples, Italy s.bimonte@istitutotumori.na.it.
Marco CascellaAnesthesia and Pain Medicine, Department of Medicine, Surgery and Dentistry Scuola Medica Salernitana, University of Salerno, Baronissi, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimChemotherapy-induced peripheral neuropathy (CIPN) is a common and disabling side-effect of various chemotherapeutic agents. This scoping review aimed to systematically map the existing literature on diagnostic methods used to identify, assess, and monitor CIPN. The review was guided by the research question: "What diagnostic methods have been used in the literature to identify, assess, or monitor chemotherapy-induced peripheral neuropathy in adult cancer patients?" MATERIALS AND

methodsWe searched PubMed, Web of Science, Scopus, and the Cochrane Library from 2000 to 2024. Studies were included if they evaluated diagnostic methods for CIPN such as clinical assessments, patient-reported outcomes, biomarkers, neurophysiological tests, or digital tools. Data were extracted and narratively synthesized by diagnostic method type. The methodological quality of each included study was assessed using the Joanna Briggs Institute Critical Appraisal Tools.

resultsTwenty-nine studies met the inclusion criteria. The most frequently used tools were patient-reported questionnaires, notably the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire - Chemotherapy-Induced Peripheral Neuropathy 20 (EORTC QLQ-CIPN20) and the National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE). Biomarkers such as neurofilament light chain and microRNAs, neurophysiological tests including nerve conduction studies, diffusion tensor imaging, functional magnetic resonance imaging, as well as digital technologies, such as mobile applications and wearable sensors, were also employed. Studies showed considerable heterogeneity in design, population, timing of assessments, and tool validation.

conclusionDespite growing interest in multimodal approaches that integrate subjective and objective tools, a lack of standardization and validation limits the clinical applicability of many diagnostic methods. There is an urgent need to develop and validate reliable, reproducible, and feasible tools for the diagnosis and monitoring of CIPN in routine practice.

Indexed as

Antineoplastic AgentsNeoplasmsNeurotoxicity SyndromesPeripheral Nervous System DiseasesBiomarkersHumansPatient Reported Outcome MeasuresQuality of LifeAntineoplastic AgentsBiomarkerscancerChemotherapy-induced peripheral neuropathyneurotoxicitypainreview

Identifiers

PMID41167691
PMCPMC12588251

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.